Nama: Sitti Hajijah Soo Nim

NAMA: SITTI HAJIJAH SOO NIM : 105421105517

INTRODUCTION

preliminary Diabetes mellitus (DM) is wrong one global health problem in the world.

World Health Organization (WHO) (2014) stated that 347 billion residents the world of diabetes diabetes and in the year 2030 diabetes is predicted to be the cause seventh major death in the world.Other research

also mention that dyslipidemia and

Platelet dysfunction is a factor cardiovascular risk in type DM patients 1, See the magnitude of the risk of morbidity and

mortality due to cardiovascular disease, then the use of drugs for prevention cardiovascular disease has a role

important. According to one therapy guideline DM published by American Diabetes Association (ADA) in 2015, therapy

statin and antiplatelet are recommended for primary and secondary prevention cardiovascular disease in DM.3 patients Several studies have shown effectiveness of statin use in terms of

primary and secondary prevention of disease cardiovascular in DM.8,9 Evidence patients the same effectiveness in reducing

risk of cardiovascular disease in patients DM is also found in use antiplatelet, especially in use low-dose aspirin.

METHOD

This research uses research methods non-experimental done cross-sectional. House sick place where this research took place is one type B hospital this pain has a bed occupancy ratio

(BOR) of approximately 80.00%. total

patients who seek treatment at poly out patient homes

this pain is around 1000 people per day. This hospital also serves participating patients Social Security Organizing Agency (BPJS) Health.

The population in this study is outpatient DM patients treated in poly

hospital outpatient during period 1 month, which is November 12 to December 15 2014. DM patients are defined as patients who gets a DM diagnosis based on

doctor's diagnosis as written on the data medical records. Likewise for diagnosis

other diseases in this study are based doctor's diagnosis written on the record data medical patient. Patients who are participants

research is those who state willingness to take part in research with signed an informed consent sheet.

The exclusion criteria were DM patients

who experienced contraindications to administration of drugs with statins, antiplatelet, or antihypertensive.

taken is 72 people. Retrieving data for each patient done by interview method for get data on patient name, age, type sex, family history, social history, and drugs used by patients.

In addition, researchers also made observations the patient's medical record data and results

laboratory tests to obtain disease history, blood pressure, profile lipid, albuminuria, complete data usage medicine and dosage. Data retrieval with these two methods are mutually exclusive complete patient data.

CONCLUSION

This study shows the use of drugs

for the prevention of cardiovascular disease (antiplatelet, statins, and ACEIs or ARBs) in patients with DM it is still not optimal. Thing

this is one of the important phenomena need to be considered by health workers because of the risk of cardiovascular disease owned by DM patients. Besides that, p

this can open opportunities for pharmacists, as one of the experts in the field of medicine, in monitoring usage drug in DM patients, in addition to use medicine to control blood sugar levels. Further research is needed

identify factors that influence low use of antiplatelet, statins, and appropriate antihypertension in patients DM so that prevention strategies are complications cardiovascular can be more effective.